periapical infection. 4 After infection has penetrated the mandible it will follow the line of least resistance, tracking along fascial planes. It may rupture into the adjacent carotid sheath and therefore progress up and down the neck. This may produce pain and tenderness as described in the distribution of the carotid artery, but there are no recent reports of these symptoms in the absence of jaw pain.
Severe spontaneous carotid pain with tenderness along the course of the common carotid artery in the absence of infection or trauma constitutes the syndrome of carotodynia.S The clinical picture is similar to that described in our patient. Pain often radiates from the neck to the ipsilateral side of the face and ear. The affected carotid artery is noticeably tender and may be distended and hyperpulsatile. Fever is unusual and a raised erythrocyte sedimentation rate is often the only abnormal laboratory finding. The condition may be a variant of migraine and often responds to ergotamine compounds.6 The differential diagnosis also includes dissecting carotid artery aneurysms,7 which are usually seen on a real time ultrasound scan of the neck. 
17-Oxogenic steroids/17-hydroxycorticoids
In patients with Cushing's syndrome the excretion of 1 7-oxogenic steroids is not always increased: for example, Crapo" found that 56 out of 235 such patients (24%) had normal daily excretion of these steroids. The assay of urine free cortisol or serum cortisol is more useful. Urine free cortisol excretion is ofparticular value as it parallels the cortisol secretion rate,7 while measurement of serum cortisol at 0800 and 2400 will often disclose a loss in the circadian rhythm of cortisol. The best first line test for Cushing's syndrome, however, is the single dose overnight dexamethasone suppression test, since this has a low incidence of false negative results. 6 When adrenal hyperfunction has been established adrenocorticotrophin plasma measurements will help to differentiate adrenal tumours from pituitary and ectopic sources of this hormone.
Measurement of 17-oxogenic steroids after the administration of metyrapone has long been advocated as a useful indirect test of adrenocorticotrophin release.8 Supporters for retaining this measurement point to the metyrapone test and cite the difficulties and cost of performing assays for adrenocorticotrophin as the direct test of release of this hormone from the pituitary after metyrapone. The specific assay of serum 1 l-deoxycortisol, however, has been found to be a rapid, useful, and acceptable alternative for the indirect detection of adrenocorticotrophin release after metyrapone administration. 9 Adrenal insufficiency may be due to destruction of the adrenal cortex or be secondary to impaired pituitary secretion of adrenocorticotrophin. In either case finding low or undetectable basal concentrations of cortisol in serum with absent or poor cortisol response to short term (30 minutes to one hour) administration of tetracosactrin confirms the diagnosis. To achieve comparable diagnostic information when urine 17-oxogenic steroids are measured requires protracted stimulation of adrenocorticotrophin and urine collections on several days. In patients with congenital adrenal hyperplasia in whom 21-hydroxylase deficiency is suspected measurement of 17-hydroxyprogesterone in serum, or its metabolite pregnanetriol in urine, is preferred to measurement of 17-hydroxycorticoids or 17-oxogenic steroids in urine.'°"
17-Oxosteroids
The use of 1 7-oxosteroids for diagnosis is even more questionable than the use of 17-oxogenic steroid or 17-hydroxycorticoid measurements.
Roughly half of patients with polycystic ovary syndrome have raised concentrations of serum A 1-androstenedione and testosterone, whereas their 17-oxosteroid excretion is normal.)2 1 A4-Androstenedione is secreted from the adrenals and gonads. Stimulation of the adrenal cortex with tetracosactrin increases the serum concentration of testosterone derived from peripheral conversion of A4-androstenedione secreted by the adrenals,'4 while failure to suppress a raised concentration of testosterone in serum suggests an ovarian source for this steroid. Discrimination between an adrenal or gonadal source of the androgens is not possible when 17-oxosteroids are measured.
Serum concentrations of 17a-hydroxyprogesterone, testosterone, and A4-androstenedione are also raised in certain rare diseases associated with sexual precocity in children, notably children with congenital adrenal hyperplasia" and prepubertal boys with Leydig cell tumours.'6 In many of these cases, especially in infancy, raised 17-oxosteroid excretion is not found.
Women with an adrenal androgen secreting tumour may present only with hirsutism. On the other hand, prepubertal children may present with advanced bone age and accelerated growth. In these circumstances assay of the adrenal steroid dehydroepiandrosterone or its sulphate is a sensitive index of the underlying disorder, epecially when the concentration is related to age.17 ', In addition, if testosterone is measured at the same time as dehydroepiandrosterone sulphate raised values are found because of the conversion of dehydroepiandrosterone to A4-androstenedione and testosterone. Less reliance can be placed on the serum testosterone concentration in men suspected of having an adrenal adenoma because of the testicular contribution of this hormone. Hence measurement of dehydroepiandrosterone or its sulphate in serum is all that is required.
The adult reference range for serum testosterone shows no overlap between the sexes. By contrast, an overlap in 17-oxosteroid excretion does occur, especially as puberty intervenes. Boys with primary testicular disease and inadequate Levdig cellfunction may readily be identified by measurement of serum testosterone concentrations before and after stimulation with human chorionic gonadotrophin. 9 Such patients cannot easily be identified when 17-oxosteroids are measured because testosterone is not detected by this assay and only a quarter of its metabolites appear in the urine.
The diagnosis of male hypogonadism is a recurring problem. Rare but well documented20 gonadal enzyme deficiencies may be the cause. The rare disease of 5a-reductase deficiency, in which there is failure to convert testosterone to the more biologically active metabolite dihydrotestosterone, may be detected by specific measurement of the metabolite,2' but 17-oxosteroid excretion is not sensitive enough to give any indication of the androgen state of these patients. Phenotypic women with testicularfeminising syndrome may also be identified by raised serum testosterone and luteinising hormone concentrations, whereas 17-oxosteroid excretion is frequently normal. This is a modified form of a paper prepared at the invitation of The Association of Clinical Biochemists' Scientific Committee Working Party for Clinical Laboratory Investigations, which first appeared in the Annals of Clinical Biochemistry (1983;20:65-71). One of the remits of this working party is to serve as an avenue for the publication of short, dogmatic, and perhaps provocative articles concerning specific aspects of current clinical laboratory practice.
Conclusion
I thank members of the Clinical Chemistry Laboratory Investigations Working Party of the ACB and many clinical colleagues for helpful advice.
